Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice
- 7 October 2010
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 25 (2), 703-713
- https://doi.org/10.1096/fj.10-171488
Abstract
Cytochrome P-450 (CYP)-derived epoxyeicosatrienoic acids (EETs) possess potent anti-inflammatory effects in vitro. However, the effect of increased CYP-mediated EET biosynthesis and decreased soluble epoxide hydrolase (sEH, Ephx2)-mediated EET hydrolysis on vascular inflammation in vivo has not been rigorously investigated. Consequently, we characterized acute vascular inflammatory responses to endotoxin in transgenic mice with endothelial expression of the human CYP2J2 and CYP2C8 epoxygenases and mice with targeted disruption of Ephx2. Compared to wild-type controls, CYP2J2 transgenic, CYP2C8 transgenic, and Ephx2(-/-) mice each exhibited a significant attenuation of endotoxin-induced activation of nuclear factor (NF)-κB signaling, cellular adhesion molecule, chemokine and cytokine expression, and neutrophil infiltration in lung in vivo. Furthermore, attenuation of endotoxin-induced NF-κB activation and cellular adhesion molecule and chemokine expression was observed in primary pulmonary endothelial cells isolated from CYP2J2 and CYP2C8 transgenic mice. This attenuation was inhibited by a putative EET receptor antagonist and CYP epoxygenase inhibitor, directly implicating CYP epoxygenase-derived EETs with the observed anti-inflammatory phenotype. Collectively, these data demonstrate that potentiation of the CYP epoxygenase pathway by either increased endothelial EET biosynthesis or globally decreased EET hydrolysis attenuates NF-κB-dependent vascular inflammatory responses in vivo and may serve as a viable anti-inflammatory therapeutic strategy.Keywords
Funding Information
- American Foundation for Pharmaceutical Education (GM31278)
- American Heart Association (GM088199, P30 DK34987)
This publication has 53 references indexed in Scilit:
- Activation of the Acute Inflammatory Response Alters Cytochrome P450 Expression and Eicosanoid MetabolismDrug Metabolism and Disposition, 2010
- Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension‐induced renal injury in miceThe FASEB Journal, 2010
- Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammationJournal of Molecular and Cellular Cardiology, 2009
- Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseasesNature Reviews Drug Discovery, 2009
- Cytochrome P450 (CYP) 2J2 gene transfection attenuates MMP‐9 via inhibition of NF‐κβ in hyperhomocysteinemiaJournal of Cellular Physiology, 2008
- Compensatory Mechanism for Homeostatic Blood Pressure Regulation in Ephx2 Gene-disrupted MicePublished by Elsevier BV ,2007
- Identification and functional characterization of polymorphisms in human cyclooxygenase-1 (PTGS1)Pharmacogenetics and Genomics, 2007
- Detection of Human CYP2C8, CYP2C9, and CYP2J2 in Cardiovascular TissuesDrug Metabolism and Disposition, 2007
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976